These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1866 related items for PubMed ID: 8148492

  • 1. In vivo effects of purified recombinant human macrophage colony-stimulating factor in combination with local hyperthermia on tumor progression in B16a melanoma bearing mice.
    Lu L, Xiao M, Wu B, Wang WX, Yan WR, Broxmeyer HE, Shen RN.
    Int J Hematol; 1993 Oct; 58(3):139-52. PubMed ID: 8148492
    [Abstract] [Full Text] [Related]

  • 2. Antitumor effect of interleukin 7 in combination with local hyperthermia in mice bearing B16a melanoma cells.
    Wu B, Shen RN, Wang WX, Broxmeyer HE, Lu L.
    Stem Cells; 1993 Sep; 11(5):412-21. PubMed ID: 8241952
    [Abstract] [Full Text] [Related]

  • 3. Effects of interleukin 2 treatment combined with local hyperthermia in mice inoculated with Lewis lung carcinoma cells.
    Shen RN, Lu L, Wu B, Shidnia H, Hornback NB, Broxmeyer HE.
    Cancer Res; 1990 Aug 15; 50(16):5027-30. PubMed ID: 2379168
    [Abstract] [Full Text] [Related]

  • 4. Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice.
    Bock SN, Cameron RB, Kragel P, Mulé JJ, Rosenberg SA.
    Cancer Res; 1991 May 15; 51(10):2649-54. PubMed ID: 2021943
    [Abstract] [Full Text] [Related]

  • 5. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA, Taylor PA, Aukerman SL, Blazar BR.
    Cancer Res; 1993 Sep 15; 53(18):4273-80. PubMed ID: 8364923
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of recombinant human macrophage colony-stimulating factor in combination with whole-body hyperthermia in the treatment of mice infected with the polycythemia-inducing strain of the Friend virus complex.
    Lu L, Shen RN, Zhou SZ, Wu B, Kim YJ, Lin ZH, Ruscetti S, Ralph P, Broxmeyer HE.
    Exp Hematol; 1991 Sep 15; 19(8):804-9. PubMed ID: 1907925
    [Abstract] [Full Text] [Related]

  • 7. In vivo effects of recombinant human interleukin 6, alone or in combination with local irradiation, on tumor growth in Lewis lung carcinoma-bearing mice.
    Lu L, Shen RN, Broxmeyer HE.
    Int J Cell Cloning; 1991 Sep 15; 9(5):511-20. PubMed ID: 1955739
    [Abstract] [Full Text] [Related]

  • 8. Cancer immunotherapy with interleukin 12 and granulocyte-macrophage colony-stimulating factor-encapsulated microspheres: coinduction of innate and adaptive antitumor immunity and cure of disseminated disease.
    Hill HC, Conway TF, Sabel MS, Jong YS, Mathiowitz E, Bankert RB, Egilmez NK.
    Cancer Res; 2002 Dec 15; 62(24):7254-63. PubMed ID: 12499267
    [Abstract] [Full Text] [Related]

  • 9. [Antitumor effect of M-CSF and/or IFN-gamma gene cotransfected-macrophages by intratumoral injection].
    Lei H, Cao X, Yu Y.
    Zhonghua Zhong Liu Za Zhi; 1998 May 15; 20(3):174-7. PubMed ID: 10920999
    [Abstract] [Full Text] [Related]

  • 10. Vascular endothelial growth factor blockade reduces intratumoral regulatory T cells and enhances the efficacy of a GM-CSF-secreting cancer immunotherapy.
    Li B, Lalani AS, Harding TC, Luan B, Koprivnikar K, Huan Tu G, Prell R, VanRoey MJ, Simmons AD, Jooss K.
    Clin Cancer Res; 2006 Nov 15; 12(22):6808-16. PubMed ID: 17121902
    [Abstract] [Full Text] [Related]

  • 11. Augmented antitumor effects of combination therapy with interleukin-12, cisplatin, and tumor necrosis factor-alpha in a murine melanoma model.
    Zagozdzon R, Stokłosa T, Gołab J, Giermasz A, Dabrowska A, Lasek W, Jakóbisiak M.
    Anticancer Res; 1997 Nov 15; 17(6D):4493-8. PubMed ID: 9494557
    [Abstract] [Full Text] [Related]

  • 12. Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer.
    Cao X, Huang X, Ju DW, Zhang W, Hamada H, Wang J.
    Cancer Gene Ther; 2000 Feb 15; 7(2):177-86. PubMed ID: 10770625
    [Abstract] [Full Text] [Related]

  • 13. Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma.
    Lei H, Ju DW, Yu Y, Tao Q, Chen G, Gu S, Hamada H, Cao X.
    Gene Ther; 2000 Apr 15; 7(8):707-13. PubMed ID: 10800095
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Antitumor effects of granulocyte-macrophage colony-stimulating factor production by melanoma cells.
    Armstrong CA, Botella R, Galloway TH, Murray N, Kramp JM, Song IS, Ansel JC.
    Cancer Res; 1996 May 01; 56(9):2191-8. PubMed ID: 8616871
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Granulocyte-macrophage colony-stimulating factor and interleukin-2 fusion cDNA for cancer gene immunotherapy.
    Stagg J, Wu JH, Bouganim N, Galipeau J.
    Cancer Res; 2004 Dec 15; 64(24):8795-9. PubMed ID: 15604233
    [Abstract] [Full Text] [Related]

  • 19. Intratumoral injection of GM-CSF gene encoded recombinant vaccinia virus elicits potent antitumor response in a mixture melanoma model.
    Ju DW, Cao X, Acres B.
    Cancer Gene Ther; 1997 Dec 15; 4(2):139-44. PubMed ID: 9080123
    [Abstract] [Full Text] [Related]

  • 20. [Therapeutic effect of vaccinia virus secreting granulocyte-macrophage colony-stimulating factor on pulmonary metastatic melanoma].
    Ju D, Cao X, Ma S.
    Zhonghua Zhong Liu Za Zhi; 1996 May 15; 18(3):165-8. PubMed ID: 9387245
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 94.